Johnson & Johnson (JNJ)
227.19
-2.66
(-1.16%)
USD |
NYSE |
May 01, 16:00
227.31
+0.12
(+0.05%)
Pre-Market: 20:00
Johnson & Johnson Free Cash Flow : 17.80B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 8.597B |
| Biogen, Inc. | 2.316B |
| Gilead Sciences, Inc. | 9.456B |
| Protagonist Therapeutics, Inc. | 56.08M |
| Moderna, Inc. | -1.603B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.514B |
| Cash from Investing (Quarterly) | -1.04B |
| Cash from Financing (Quarterly) | 530.00M |
| Free Cash Flow Per Share (Quarterly) | 0.5991 |
| Free Cash Flow to Equity (Quarterly) | -4.189B |
| Free Cash Flow to Firm (Quarterly) | 1.830B |
| Free Cash Flow Yield | 3.22% |